By growing human retinal tissue from stem cells, researchers have determined how the various types of cells that enable people to see colors develop. The new study sets the stage for the development of therapies and treatments for eye diseases like color blindness or macular degeneration.
What's more, the results - some of the first such vision research to be done on human tissue, versus that of mice or fish - further establish lab-grown organoids as a powerful model for studying mechanisms underlying human development.
Three types of cone photoreceptors are present in the retina, which respond to different wavelengths of light according to their pigments to give humans color vision. Mutations that affect the expression or function of these light-sensitive proteins are known to cause forms of color blindness and other eye diseases. According to the authors, however, little is known about how the specialized blue-opsin (short wavelength; S), green-opsin (medium wavelength; M), or red-opsin (long wavelength; L) cell subtypes develop in the human retina.
In the lab researchers grew stem cells into retinal tissue organoids that closely mirrored the developmental stages observed in in vivo retinal tissue. They found that blue-detecting cones developed first, followed by red- and green-detecting ones. In retinal organoids that lacked thyroid hormone receptor β (Thrβ), all cones developed into the S subtype. Thrβ binds with high affinity to triiodothyronine (T3), the more active form of TH, to regulate gene expression. Authors observed that addition of T3 early during development induced L/M fate in nearly all cones. Thus, TH signaling through Thrβ is necessary and sufficient to induce L/M cone fate and suppress S fate. TH exists largely in two states: thyroxine (T4), the most abundant circulating form of TH, and T3, which binds TH receptors with high affinity.
Authors found that deiodinase 3 (DIO3), an enzyme that degrades both T3 and T4, was expressed early in organoid and retina development. Conversely, deiodinase 2 (DIO2), an enzyme that converts T4 to active T3, as well as TH carriers and transporters, were expressed later in development. Temporally dynamic expression of TH-degrading and -activating proteins supports a model in which the retina itself controls TH levels, ensuring low TH signaling early to specify S cones and high TH signaling later in development to produce L/M cones.
Researchers note that their results provide insight into why pre-term infants with low levels of thyroid hormone often have a higher incidence of color vision defects.
http://science.sciencemag.org/content/362/6411/eaau6348
Latest News
Mutations in noncoding DNA…
By newseditor
Posted 24 Apr
More influence of environme…
By newseditor
Posted 24 Apr
The assembly of the human c…
By newseditor
Posted 24 Apr
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Other Top Stories
How bacteria cope with stress
Read more
Pain neuron-derived peptide prevents endotoxic death!
Read more
How stress hormones guide bacteria in their host
Read more
Malaria parasite's survival linked to two proteins
Read more
Machine learning to design better viral diagnostics
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Massively parallel screen u…
By newseditor
Posted 24 Apr
Distinct genetic and enviro…
By newseditor
Posted 24 Apr
Hippocampus-to-amygdala pat…
By newseditor
Posted 24 Apr
Integrative spatial analysi…
By newseditor
Posted 24 Apr
Time-series reconstruction…
By newseditor
Posted 24 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar